Arcus Biosciences, Inc. <RCUS.N>: TD Cowen Initiates Coverage With Buy Rating
RCUS•Related News
Lionsgate Studios held annual shareholder meeting with 91.47% shares represented
LION•
NeurAxis to present at Lytham Partners Fall 2026 Investor Conference
NRXS•
Compass Pathways joins TD Cowen Novel Mechanisms in Neuropsychiatry Summit fireside chat
CMPS•
Rivian Chief Administrative Officer Michael John Callahan disposes of 15,000 shares for $244,391
RIVN•
NOV schedules third-quarter earnings conference call
NOV•